LSE - Delayed Quote GBp

GSK plc (GSK.L)

1,855.00 +41.00 (+2.26%)

At close: 5:15:00 PM GMT

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

Chiesi Group appoints Paolo Paoletti to its Board of Directors

Business Wire 1d ago

LLY

GSK
Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)

GlobeNewswire 4mo ago

GSK.L
+2.26%
SPRO

GSK
Nicotine Gum Market Analysis Report 2026-2035: A $2.55 Billion Market by 2030 with Pfizer, GlaxoSmithKline, Haleon, Perrigo Co, and Johnson & Johnson Leading

GlobeNewswire 8mo ago

PFE

GSK.L
+2.26%
HLN.L
Kernicterus Market Research and Forecast Report 2026-2036 Featuring Pfizer, F.Hoffmann La Roche,. Merck, AbbVie, AsteraZeneca, Abbott Laboratories, Sanofi, GlaxoSmithKline, Grifols

GlobeNewswire 5mo ago

PFE

MRK

ABBV
Benlysta Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan

GlobeNewswire 5mo ago

GSK.L
+2.26%
Anti-Cancer MAbS Market Report 2026-2030 Featuring Strategic Analysis of Amgen, Bristol Myers Squibb Company, Eli Lilly and Company, Roche, GlaxoSmithKline and Other Key Players

GlobeNewswire 7mo ago

AMGN

BMY

LLY
Systemic Lupus Erythematosus Market at a Turning Point as 6 Late-Stage Emerging Therapies Set to Redefine Treatment Landscape | DelveInsight

PR Newswire 3mo ago

BIIB

GSK.L
+2.26%
AZN.L
Sona Nanotech Appoints Seasoned Biotech Commercial Executive Michael A. Fleming to Board of Directors

CNW Group 4mo ago

SONA.CN

CHRS

GSK.L
+2.26%
Pancreatic Adenocarcinoma Treatment Market to Grow at 13% CAGR During 2026-2030, Led by Pfizer, Roche, Merck & Co., Sanofi, Bristol-Myers Squibb, AstraZeneca, Novartis, and GlaxoSmithKline

GlobeNewswire 6mo ago

PFE

MRK

SAN.PA
Cipla Receives U.S. FDA Approval for First AB-Rated Generic of Ventolin® HFA

PR Newswire 6mo ago

CIPLA.NS

GSK.L
+2.26%
[Latest] Global GLP-1 Receptor Agonist Market Size/Share Worth USD 95.3 Billion by 2035 at a 12.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

GlobeNewswire 4mo ago

PFE

MRK

ZEAL.CO
Onco-Innovations Announces Inka Health Collaborative Research to Advance Oncology Evidence Generation

ACCESS Newswire 5mo ago

ONCO.NE

CBOE

GSK.L
+2.26%

Performance Overview

Return	GSK.L	FTSE 100 (^FTSE)
YTD	+1.70%	+8.04%
1-Year	+4.07%	+9.94%
3-Year	+27.87%	+46.43%

U.S. markets closed

GSK plc (GSK.L)

Chiesi Group appoints Paolo Paoletti to its Board of Directors

Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)

Nicotine Gum Market Analysis Report 2026-2035: A $2.55 Billion Market by 2030 with Pfizer, GlaxoSmithKline, Haleon, Perrigo Co, and Johnson & Johnson Leading

Kernicterus Market Research and Forecast Report 2026-2036 Featuring Pfizer, F.Hoffmann La Roche,. Merck, AbbVie, AsteraZeneca, Abbott Laboratories, Sanofi, GlaxoSmithKline, Grifols

Benlysta Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan

Anti-Cancer MAbS Market Report 2026-2030 Featuring Strategic Analysis of Amgen, Bristol Myers Squibb Company, Eli Lilly and Company, Roche, GlaxoSmithKline and Other Key Players

Systemic Lupus Erythematosus Market at a Turning Point as 6 Late-Stage Emerging Therapies Set to Redefine Treatment Landscape | DelveInsight

Sona Nanotech Appoints Seasoned Biotech Commercial Executive Michael A. Fleming to Board of Directors

Pancreatic Adenocarcinoma Treatment Market to Grow at 13% CAGR During 2026-2030, Led by Pfizer, Roche, Merck & Co., Sanofi, Bristol-Myers Squibb, AstraZeneca, Novartis, and GlaxoSmithKline

Cipla Receives U.S. FDA Approval for First AB-Rated Generic of Ventolin® HFA

[Latest] Global GLP-1 Receptor Agonist Market Size/Share Worth USD 95.3 Billion by 2035 at a 12.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Onco-Innovations Announces Inka Health Collaborative Research to Advance Oncology Evidence Generation